Session Synopsis: Several important, recently launched government initiatives have as a central focus disease prevention, diagnosis, and treatment. This session will provide a broad update on these initiatives, but will also focus on the technical challenges and potential solutions of precision medicine in the near and longer term which includes vision of precision medicine analytics and big data and the integration of wearables and everyday tech.
Session Chair Profile
Director, All of Us Research Program, National Institutes of Health
Eric Dishman is the Director of the All of Us Research Program (previously the Precision Medicine Initiative® Cohort Program) at the National Institutes of Health. In this role, he leads efforts to build a research cohort of one million U.S. participants to advance precision medicine. Previously, Eric was an Intel Fellow and Vice President of the Health and Life Sciences Group at Intel Corporation, where he was responsible for driving Intel’s cross-business strategy, research and development, and product and policy initiatives for health and life science solutions. He is widely recognized as a global leader in health care innovation with specific expertise in home and community-based technologies and services for chronic disease management and independent living. Trained as a social scientist, Dishman is known for pioneering innovation techniques that incorporate anthropology, ethnography, and other social science methods into the development of new technologies. He also brings his own experience as a cancer patient for 23 years—finally cured thanks to precision medicine—to drive a person-centric view of health care transformation.
Ph.D., Program Director, Human Microbiome Project
As Program Director, Dr. Proctor is responsible for coordination of the Human Microbiome Project (HMP). The HMP is an eight-year, trans-NIH Common Fund Initiative to create a toolbox of resources for this emerging field. Resources developed so far include bacterial, viral, and fungal strains and their genome sequences, data gathered from these studies developed as community resources, and computational tools used to analyze these complex data sets. Dr. Proctor joined the Division of Genomic Sciences in the Extramural Research Program in 2010. Prior to this she served as Program Director at the National Science Foundation (NSF) in the Geosciences and the Biosciences Directorates, where she managed microbiological, bioinformatics and research resources programs. She is formally trained in microbial ecology, was a National Science Foundation (NSF) Postdoctoral Fellow in molecular microbial genetics at the University of California, Los Angeles, and has held appointments at Florida State University and at the University of California, Santa Cruz.
Engineering Director, Google
David is an engineering director at Google, currently helping life science organizations use Google’s Cloud Platform to accelerate and scale their work with big data. His previous projects at Google include creating and leading the Google+ Platform team, overseeing the company’s developer-facing offerings, and leading product and infrastructure teams for Google Apps. Prior to joining Google in 2006, he successfully started two companies: Verity in 1988 (IPO 1995), which did full-text search, and Eloquent in 1995 (IPO 2000), which used rich media to power business communications. Eloquent was later acquired by Open Text, an enterprise software firm, where David served as CTO. David grew up in Massachusetts, where he earned a BS in physics from MIT.
Greg Simon served as the Executive Director of the White House Cancer Moonshot Task Force, a position created by President Barack Obama and for which he was chosen by Vice President Joe Biden in March 2016. Over the past nine months Greg and his team helped launch over seventy innovative collaborations. Greg returns to the White House after serving as Vice President Al Gore’s Chief Domestic Policy Advisor between 1993 and 1997. Greg was the CEO of Poliwogg, a financial services company creating unique capital market opportunities in healthcare and life sciences. Previously, Greg was Senior Vice President for Worldwide Policy and Patient Engagement at Pfizer, co-founded with Michael Milken, FasterCures/ The Center for Accelerating Medical solutions, and with Leon and Debra Black co-founded the Melanoma Research Alliance. Greg is a cancer survivor, having been recently successfully treated for chronic lymphocytic leukemia.